You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET MTC

Showing 1 - 25 of 167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

Active, not recruiting
  • Advanced Nonhaematologic Malignancies
  • Philadelphia, Pennsylvania
  • +20 more
Sep 23, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Vandetanib in RET -/+ Metastatic Medullary Thyroid Cancer

Completed
  • Symptomatic, Aggressive, Sporadic, Unresectable, Locally
  • Advanced/Metastatic Medullary Thyroid Cancer (MTC)
  • Vandetanib 300 mg
  • Belgium, Belgium
  • +7 more
Oct 15, 2020

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 17, 2022

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

Children and Adults With Medullary Thyroid Cancer

Recruiting
  • Medullary Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

    Enrolling by invitation
    • Diabetes
    • +3 more
    • No treatment given
    • Morgantown, West Virginia
      United BioSource, LLC
    Oct 4, 2022

    Metastatic Sporadic Medullary Thyroid Cancer Patients and

    Completed
    • Metastatic Sporadic Medullary Thyroid Cancer
      • Milano, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
      Sep 29, 2021

      Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

      Recruiting
      • Non Small Cell Lung Cancer
      • +4 more
      • Irvine, California
      • +15 more
      Mar 9, 2022

      Advanced Solid Tumor Trial in Chengdu (KL590586 Capsule)

      Enrolling by invitation
      • Advanced Solid Tumor
      • KL590586 Capsule
      • Chengdu, Sichuan, China
        Sichuan Kelun Botai Biopharmaceutical Co.
      Feb 23, 2022

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

      Not yet recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +3 more
      • Chang chun, Jilin, China
        Jinlin Province Cancer Hosipital
      Dec 21, 2022

      Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

      Completed
      • Medullary Thyroid Carcinoma
      • Nodular Goiter
      • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
      • Pilar, Buenos Aires, Argentina
        Hospital Universitario Austral
      Oct 5, 2023

      Thyroid Carcinoma

      Recruiting
      • Differentiated Thyroid Carcinoma
      • Medullary Thyroid Carcinoma
      • Immunohistochemistry (IHC)
      • +2 more
      • L'Hospitalet De Llobregat, Barcelona, Spain
      • +11 more
      Mar 22, 2022

      Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)

      Recruiting
      • Metastic Thyroid Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Advanced Solid Tumor Trial (HEC169096)

      Not yet recruiting
      • Advanced Solid Tumor
      • (no location specified)
      Jul 6, 2022

      Advanced Solid Tumor Trial in Shanghai (HS269)

      Not yet recruiting
      • Advanced Solid Tumor
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Sep 24, 2021

      Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

      Recruiting
      • Medullary Thyroid Cancer
      • Birmingham, Alabama
      • +148 more
      Jan 18, 2023

      Medullary Thyroid Cancer Trial (Ponatinib)

      Withdrawn
      • Medullary Thyroid Cancer
      • (no location specified)
      Oct 6, 2021

      Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

      Recruiting
      • Medullary Thyroid Cancer
      • Anlotinib Hydrochloride Capsule
      • Hefei, Anhui, China
      • +18 more
      Apr 14, 2023

      A Taiwanese Oncogenetic Panel and Integrated Clinical Data

      Recruiting
      • Thyroid Cancer
      • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
      • Kaohsiung, Taiwan
      • +7 more
      Sep 12, 2022

      Clostridiodies Difficile Infections Trial in New York (MTC 01, Fecal Microbiota Transplantation (FMT))

      Not yet recruiting
      • Clostridiodies Difficile Infections
      • MTC 01
      • Fecal Microbiota Transplantation (FMT)
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jun 12, 2023

      Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

      Recruiting
      • Nonsmall Cell Lung Cancer
      • HS-10365 capsules
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Nov 22, 2023